HomeMDGL • NASDAQ
add
Madrigal Pharmaceuticals Inc
Previous close
$369.84
Day range
$351.32 - $375.76
Year range
$200.63 - $377.46
Market cap
8.33B USD
Avg Volume
407.58K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 212.80M | 1,353.76% |
Operating expense | 250.94M | 42.14% |
Net income | -42.28M | 72.18% |
Net profit margin | -19.87 | 98.09% |
Earnings per share | -1.90 | 73.24% |
EBITDA | -46.82M | 71.14% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 797.02M | -24.65% |
Total assets | 1.02B | -7.67% |
Total liabilities | 319.40M | 31.62% |
Total equity | 695.98M | — |
Shares outstanding | 22.29M | — |
Price to book | 11.81 | — |
Return on assets | -11.73% | — |
Return on capital | -14.30% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -42.28M | 72.18% |
Cash from operations | -47.05M | 65.13% |
Cash from investing | 47.86M | 139.20% |
Cash from financing | 1.74M | -98.70% |
Net change in cash | 2.55M | 102.07% |
Free cash flow | -37.77M | 58.99% |
About
Founded
2011
Headquarters
Website
Employees
528
